Sept 21 (Reuters) – Recursion Pharmaceuticals, Inc. : * TEMPUS AND RECURSION EXTEND EXISTING DATA LICENSE AGREEMENT AND ENTER NEW LICENSE AGREEMENT FOR RECURSION’S RNA FOUNDATION MODEL * TEMPUS AI, –
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
UKMTO: MASTER REPORTS ALL CREW ARE SAFE AND NO ENVIRONMENTAL IMPACT, TANKER WILL CONTINUE TO…
Sept 21 (Reuters) - Paramount Skydance has reached a settlement with California and other states…
New Delhi [India], September 21: Forteasia Realty Private Limited has announced rapid progress on its…
S&P 500 COMMUNICATION SERVICES SECTOR INDEX AT HIGHEST SINCE AUG 5, LAST UP 3% (The…
Sept 21 (Reuters) - Paramount Skydance has reached a settlement with California and other states…
Sept 21 (Reuters) - Belgian cybersecurity firm Aikido on Monday released an open-weight artificial intelligence…